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ABSTRACT: We report the construction of erythrocyte membrane-cloaked Janus
polymeric motors (EM-JPMs) which are propelled by near-infrared (NIR) laser
irradiation and are successfully applied in thrombus ablation. Chitosan (a natural
polysaccharide with positive charge, CHI) and heparin (glycosaminoglycan with
negative charge, Hep) were selected as wall materials to construct biodegradable and
biocompatible capsules through the layer-by-layer self-assembly technique. By
partially coating the capsule with a gold (Au) layer through sputter coating, a NIR-
responsive Janus structure was obtained. Due to the asymmetric distribution of Au, a
local thermal gradient was generated upon NIR irradiation, resulting in the
movement of the JPMs through the self-thermophoresis eﬀect. The reversible “on/
oﬀ” motion of the JPMs and their motile behavior were easily tuned by the incident
NIR laser intensity. After biointerfacing the Janus capsules with an erythrocyte
membrane, the EM-JPMs displayed red blood cell related properties, which enabled
them to move eﬃciently in relevant biological environments (cell culture, serum,
and blood). Furthermore, this therapeutic platform exhibited excellent performance in ablation of thrombus through
photothermal therapy. As man-made micromotors, these biohybrid EM-JPMs hold great promise of navigating in vivo for
active delivery while overcoming the drawbacks of existing synthetic therapeutic platforms. We expect that this biohybrid
motor has considerable potential to be widely used in the biomedical ﬁeld.
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Man-made micro/nanomotors with autonomousmovement have recently drawn much attention.1−3Over the past decade, impressive progress in
designing powerful micro/nanomachines based on various
propulsion mechanisms has led to advances in biomedical
applications, such as drug delivery,4−6 precision surgery,7 cell
sensing,8,9 diagnostics, and therapy.10,11 Although current
powerful motors have been well designed, proper attention
needs to be paid to overcome a number of main challenges for
performing complex tasks in a physiologically relevant environ-
ment. Most motors are propelled by kinetic energy derived
from chemical reactions, which often requires the usage of less
compatible substrates such as hydrogen peroxide and
hydrazine, with limited control over the directionality of
movement.12 Light, magnetic ﬁeld, ultrasound, and electrically
driven motors are well-designed recently to overcome this
obstacle.13−15 Furthermore, the majority of nano- and micro-
motors still rely on synthetic materials, although micro/
nanomotors themselves can be constructed out of naturally
occurring building blocks. As a result, undesired immunoge-
nicity and biofouling still present a tough challenge for these
artiﬁcial motors, which hampers their performance in a clinical
setting. Consequently, from a clinical point of view, it is
necessary to explore the next generation of fuel-free self-
propelled motors that have a clear biosafety proﬁle as well as
precisely controlled motion. Natural polysaccharides are an
ideal candidate material for the construction of such drug
delivery systems with improved behavior in a physiological
environment. These polymers are nontoxic, biocompatible, and
biodegradable.16 In addition, some of them, such as heparin,
have therapeutic activity and can be used not only as building
blocks but also as treatment modality. As the active component
is an integral part of the particle structure, side eﬀects induced
by drug leaking will be eﬀectively avoided.
In order to minimize undesired interactions with the immune
system even further, particles can be decorated with a cell-
derived coating. As the most abundant cells in blood,
erythrocytes with their physical and chemical properties are
intrinsically biocompatible, biodegradable, and nonimmuno-
genic materials.17 Due to the protein makeup on their surface,
erythrocytes display a long-circulation behavior within a
physiological environment.18 However, conventional chemical
or biological approaches would be impractical for mimicking
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the complex membrane structure and physiological properties.
A recent, highly promising approach to confer biomimetic
surface properties onto nanoparticles is to decorate them with
the isolated membrane of erythrocytes, or red blood cells
(RBCs).19−22 By introducing a cell membrane coating,
synthetic materials have shown capability for accomplishing
comprehensive biological applications ranging from drug
delivery, toxin absorption, and immune evasion.23 Hence, for
synthetic motors, direct cloaking with a cell-derived membrane
is a convenient way to install the desired behavior in a
biological environment onto the particles.24−27 Considerable
progress has been made on designing biomimetic inorganic
particle-based motors, like RBC membrane-coated gold nano-
wire motors, Mg Janus motors, and platelet-membrane-cloaked
magnetic helical nanomotors,28−30 whereas there are still no
reports about combining this cell membrane coating strategy
with polymer-based micro/nanomotors.
In this report, we describe the successful preparation of
Janus-type polymeric micromotors (JPMs) composed of
heparin (Hep) and chitosan (CHI), which are decorated with
a stealth layer originating from an erythrocyte membrane. Due
to the opposite surface charges, the two natural polymers can
be assembled into capsules via a layer-by-layer (LbL)
procedure. Here, Hep not only is a structural component of
the capsule but also has biological function, in the sense that it
can be used to prevent or dissolve blood clotting, or
thrombosis. To ensure fuel-less propulsion, the LbL capsules
are partially covered with a gold shell in order to employ near-
infrared (NIR) irradiation to achieve motion via the photo-
thermal eﬀect. Again, NIR irradiation has a double function, as
it will not only be used for motion but can also be used for
photothermal ablation of thrombus. The sensitivity to NIR
irradiation is therefore explored to induce motor function in a
biological environment such as blood and in a thrombus disease
model to evaluate the eﬃcacy of photothermal therapy. The in
vitro experiments demonstrate that the combined properties of
these JPMs provide a safe and eﬃcient platform for
thrombolytic therapy.
RESULTS AND DISCUSSION
Janus-type polyelectrolyte microcapsules composed of poly-
saccharides were prepared in three steps (Figure 1A). First, the
LbL self-assembly technique allowed the construction of
polymeric particles. Brieﬂy, template silica particles (diameter
5 μm) were alternately exposed to CHI and Hep solutions
under continuous shaking, leading to LbL assembly. After
assembly of ﬁve double layers, the corresponding polymeric
particles were washed three times to remove the unassembled
polymers. During this process, surface charge reversal of the
polymeric particles was monitored by dynamic light scattering
(DLS). As shown in Figure S1, Hep and CHI were successfully
assembled on the surface of the templates.
Figure 1. Preparation and characterization of biodegradable JPMs. (A) Schematic illustration of synthetic procedure of JPMs by combining
the LbL self-assembly technique with the metal sputter-coating method. (B) Scanningn electron microscopy (SEM) image of as-prepared
JPMs before dissolving the template. Scale bar = 20 μm. (C) Energy-dispersive X-ray spectroscopy elemental mapping analysis for gold and
oxygen before removal of the template. Scale bar = 2 μm. (D) SEM image of JPMs after removing the template. Scale bar = 2 μm. (E)
Confocal laser scanning microscopy image of JPMs. Rhodamine B was used as the ﬂuorescence tag to prove that the Janus structure was
obtained after coating with gold. Scale bar = 2 μm. (F) Corresponding ﬂuorescence intensity proﬁle of JPMs in panel E.
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Second, in order to form the Janus structure, polymeric
particles were deposited as a monolayer on the surface of a
silicon wafer (Figure S2), and then a gold shell was introduced
selectively on part of the particles via a sputter-coating
approach (Figure 1B). Energy-dispersive X-ray spectroscopy
(EDX) elemental mapping analysis for gold and oxygen (Figure
1C) conﬁrmed the Janus morphology. Third, to form JPMs
with a hollow structure, the templates were then removed, as
Figure 2. Modiﬁcation of JPMs with an erythrocyte membrane (EM) by the vesicle fusion method. (A) Schematic illustration of the
modiﬁcation of gold-coated JPMs with an erythrocyte membrane coating. (B) CLSM images of JPMs after coating with the membrane. Green
ﬂuorescence corresponds to the Alexa Fluor 488 which stained the EM. Scale bar = 10 μm. (D) ζ-Potential (mV) of EM vesicles and JPMs
before and after coating with the cell membrane. (D) BCA assay for quantiﬁcation of protein concentration of JPMs before and after coating.
Figure 3. Movement analysis of EM-JPMs. (A) Velocity of EM-JPMs as a function of laser power. Inset image is the schematic representation
of the movement of EM-JPMs driven by the NIR laser. (B) Mean square displacement (MSD) as a function of laser power. (C) Diﬀusion
coeﬃcient as a function of laser intensity. (D) Tracking trajectories of EM-JPMs as a function of laser ﬂuence (0, 0.08, 0.81, and 2.43 J/cm2).
(E) CLSM images of one cycle movement of EM-JPMs by illumination with 0.41 J/cm2 laser. Scale bar = 20 μm. (F) Real time “on−oﬀ”
velocity control by irradiation with or without NIR laser (10 cycles).
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shown in Figure 1D. The resulting Au-functionalized Janus
structure was characterized by confocal laser scanning
microscopy (CLSM), as presented in Figure 1E. Here,
polymeric capsules were labeled by rhodamine B. After we
coated half of the capsule with a shell of gold, half of the red
ﬂuorescence of the capsule had disappeared (Figure 1F).
Erythrocytes, as natural long-circulating delivery vehicles, are
intrinsically biocompatible, biodegradable, and nonimmuno-
genic.31 Due to their surface makeup (a myriad of proteins,
glycans, and acidic sialyl moieties), erythrocytes achieve long-
term circulation in a physiological environment.32 By cloaking
the JPMs with the isolated erythrocyte membrane, we expected
that we could also introduce similar physicochemical character-
istics and biological functions of erythrocytes that would
otherwise be diﬃcult to mimic. First, erythrocyte membrane
vesicles were derived from natural erythrocytes (Figure S3).
The as-prepared vesicles were then coated on the surface of
JPMs by a vesicle fusion method,33,34 as shown in Figure 2A.
Because the entire membrane was translocated, all biologically
relevant surface moieties and membrane-bound proteins were
also transferred to the surface of the JPMs. The successful
transfer was demonstrated via a cell membrane targeting
ﬂuorescent dye (Wheat germ agglutinin, Alexa Fluor 488
conjugate), which could also stain the erythrocyte membrane-
coated JPMs (EM-JPMs, Figure 2B). Furthermore, ζ-potential
measurements by DLS also proved the successful coating with
the cell membrane (Figure 2C), as the surface charge of the
JPMs was changed from positive to negative and to a value
comparable to one measured for the cell membrane vesicles.
Next, a protein bicinchoninic acid (BCA) assay was used to
quantify the protein content before and after membrane
coating. As presented in Figure 2D, bare JPMs showed the
absence of detectable protein. A signiﬁcant increase in protein
content was observed after the membrane fusion treatment.
Meanwhile, SDS-PAGE was conducted to separate the
associated cell membrane proteins of the EM-JPMs. Bare
capsules and membrane vesicles as control groups were also
analyzed (Figure S3C). EM-JPMs showed the typical bands
that are similar to the membrane vesicles, conﬁrming the
presence of the corresponding membrane.
NIR laser-powered motors have been recognized for their
great potential in biomedical applications. Recently, a carbona-
ceous nanobottle motor based on NIR-driven jet propulsion
was designed, which relied on the photothermal eﬀect of the
carbon shell.35 Gold hybrid polymers have a similar photo-
thermal eﬀect, which makes them also suitable to be used as
man-made motors. It has been demonstrated that laser-induced
localized heating could be obtained by integrating plasmonic
gold materials into LbL-assembled polymers.36−39 In the case of
our JPMs, irradiation with a NIR laser led to the formation of a
temperature gradient around the particles due to the
asymmetric Au coating. As a result, the JPMs experienced a
force moving toward the nonheated side. Consequently, they
were able to display directed motion via the thermophoretic
eﬀect.40 The UV−vis−NIR spectra of the EM-JPMs in Figure
S4A revealed that the maximum absorption peak of this
structure was located in the NIR window, which is the key
condition for obtaining the optimal photothermal conversion
eﬀect.41 Thus, two-photon confocal laser scanning microscopy
(TP-CLSM) employing a NIR laser source with wavelength of
760 nm was used to induce and record the movement. The
extent of movement was facilely tuned by the incident laser
intensity, as shown in Figure 3A. The velocity of the EM-JPMs
was linear to the NIR laser ﬂuence. Additionally, the mean
square displacement (MSD) versus Δt and the diﬀusion
coeﬃcient (D) (D = MSD/(i × Δt), where i is the dimensional
index and Δt is the time interval) were calculated from the
recorded video (Figure 3B,C).42−44 Furthermore, the tracking
trajectory of the JPMs in phosphate-buﬀered saline (PBS)
solution as a function of laser ﬂuence was captured by ImageJ
Figure 4. Diﬀerences in movement behavior of JPMs before and after coating with an erythrocyte membrane, as a function of solution (PBS,
cell culture medium, serum, and blood). (A) Velocities and diﬀusion coeﬃcients of JPMs before erythrocyte membrane camouﬂaging. (B)
Velocities and diﬀusion coeﬃcients of EM-JPMs.
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software and is plotted in Figure 3D and Figure S4B.
Obviously, EM-JPMs display typical Brownian motion without
illumination with the NIR laser (Video S1). In sharp contrast,
with increasing NIR laser ﬂuence, the EM-JPM trajectories
were clearly extended (Video S2). The above-mentioned data,
including velocity, MSD calculations, diﬀusion coeﬃcients, and
trajectories, conﬁrmed that the movement of EM-JPMs can be
easily tuned by the incident NIR laser power. In addition, 10
“oﬀ/on” cyclic tests of the movement were conducted to prove
that this movement is repeatable and recyclable. As shown in
Figure 3E,F, taken from Video S3, once the NIR laser was
switched oﬀ, the EM-JPMs completely stopped their motion,
whereas the motion was restarted immediately after the NIR
laser source was switched on.
One of the main limitations of application of man-made
motors in a biological environment is the reversible/irreversible
adsorption of proteins and other biomolecules on the surface of
motors, which can strongly aﬀect the motion capability. The
coating of the JPMs with the erythrocyte membrane should
introduce antibiofouling properties and leave motion un-
aﬀected.28,29,45 Hence, the propulsion performance and
antibiofouling of EM-JPMs in several biological ﬂuids (PBS,
cell culture medium, serum, and blood) were tested. In PBS,
coated and bare JPMs displayed similar velocities and diﬀusion
coeﬃcients which had a linear relationship with the incident
laser ﬂuence. In the other three environments tested (cell
culture medium, serum and blood), this linear dependence
could still be observed for both particles, but EM-JPMs under
the same conditions moved signiﬁcantly faster than the
uncoated JPMs (Figure 4). Furthermore, relative velocities
and relative diﬀusion coeﬃcients were also calculated to
compare the diﬀerences between bare JPMs and EM-JPMs,
as shown in Figure S5. The maximum speed for the EM-JPMs
reached 19.8 μm/s (PBS), 12.10 μm/s (medium), 3.52 μm/s
(serum), and 2.33 μm/s (blood), which corresponds to relative
speeds of nearly 3.96, 2.42, 0.7, and 0.47 body lengths/s,
respectively. Obviously, all particles move slower when in
contact with a more viscous environment. However, after
modiﬁcation with the cell membrane, EM-JPMs moved faster
and longer in the biological environments than the bare ones.
In order to directly correlate this behavior to the antibiofouling
eﬀect, bare JPMs and membrane-modiﬁed JPMs were cultured
Figure 5. Characterization of photothermal ablation of thrombus. (A) Schematic illustration. (B) Turbidity assay using the UV absorbance at
340 nm during the formation of the thrombus model out of puriﬁed ﬁbrinogen. (C) SEM image of the as-prepared thrombus model. Scale bar
= 500 nm. (D) CLSM image of the ﬂuorescent thrombus prepared by Alexa Fluor 488-conjugated ﬁbrinogen. Scale bar = 5 μm. (E) Time-
lapsed TP-CLSM images of ﬂuorescent thrombus in the presence of EM-JPMs irradiated by a 760 nm NIR laser. Scale bar = 20 μm. (F) Time-
lapsed TP-CLSM images of ﬂuorescent ﬂoating ﬁbrin clots in the presence of EM-JPMs upon NIR irradiation (760 nm). Scale bar = 20 μm.
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in PBS solution, cell culture medium, serum, and blood at 37
°C for 1 and 6 h. Then the morphology of the particles was
characterized immediately with scanning electron microscopy
(SEM). For better observation, templates were not removed.
As shown in Figure S6, both the bare JPMs and EM-JPMs still
maintained their Janus structure in PBS solution. However, the
bare JPMs were aggregated together in cell culture medium,
serum, and whole blood and showed a roughened surface
(Figure S7). With the protection of the erythrocyte membrane,
EM-JPMs were barely aﬀected, which could be the reason that
the movement of EM-JPMs in biological ﬂuids was enhanced.
In order to be suitable for biomedical applications, the
materials applied have to be biocompatible and biodegradable.
Consequently, to ascertain the biocompatibility of EM-JPMs, a
standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay was used to evaluate the proliferation
of mice embryonic ﬁbroblast cells (NIH/3T3), which were
precultured with samples for 24 h. As shown in Figure S8, EM-
JPMs exhibit excellent biocompatibility. Furthermore, the
biodegradation of JPMs in the presence of PBS (pH 7.4) at
37 °C as a function of time (1, 3, 6, and 24 h) was also
evaluated. We performed SEM to observe the morphological
changes for these speciﬁc time periods, as shown in Figure S9.
Due to the usage of the natural polysaccharide (CHI) and
glycosaminoglycan (Hep) as wall materials, JPMs exhibited
good performance in biodegradability. Furthermore, weakened
interactions between the LbL layers due to the charge shielding
induced by PBS and the eﬀect of osmotic pressure might result
in the breakage of the capsules.46−48
To assess the eﬃcacy of thrombolysis of EM-JPMs (Figure
5A), human ﬁbrinogen was used as raw material to construct a
thrombus model by application of thrombin. The process of
ﬁbrin polymerization was monitored by using a turbidity assay
which measured the absorbance (340 nm) at 37 °C for 70 min.
The obtained column diagram, as shown in Figure 5B, reﬂected
the assembly kinetics for thrombus formation, which reached its
plateau around 60 min. Consequently, the thrombus model
used to assess thrombolysis was incubated for 60 min and
characterized by SEM (Figure 5C). In order to visualize the
eﬃcacy of ﬁbrinolysis, a ﬂuorescent thrombus was generated by
adding Alexa Fluor 488-conjugated human ﬁbrinogen to the
above-mentioned ﬁbrinogen solution. The resulting ﬂuorescent
thrombus was analyzed immediately by CLSM. As shown in
Figure 5D, a green ﬂuorescent signal proved that a ﬂuorescently
labeled thrombus model was successfully established. To
evaluate the eﬃcacy of EM-JPMs for photothermal ablation
of thrombus, the thrombus model was constructed by
polymerizing ﬁbrinogen on a μ-Slide 8 well in the presence
of 50 μL of EM-JPMs (∼4.9 × 105 per μL), followed by
irradiation with a 760 nm NIR laser for 10 min (2.43 J/cm2).
The whole process during thrombolytic therapy in situ was
analyzed by CLSM. Time-lapsed CLSM images were recorded
and are shown in Figure 5E. Here, the green ﬂuorescence
images represent the thrombus model (polymerized ﬁbrino-
gen), and the red ﬂuorescent signal originated from EM-JPMs.
The results displayed destruction of the ﬁbrin network with
NIR laser irradiation as the ﬂuorescence of thrombus was
gradually released and spread to neighboring areas. The
corresponding video can be found in the Supporting
Information (Video S4), which shows the clot dissolution in
real time. To demonstrate the combined function of motion
and photothermal ablation,49,50 a ﬁbrin clot was prepared by
detaching the ﬁbrin network and redispersing the thrombus in
solution. Interestingly, by irradiation with the NIR laser, EM-
JPMs with red ﬂuorescence were aggregated around the ﬂoating
ﬁbrin clot and then achieved eﬃcient thrombolysis (Figure 5F
and Video S5). In order to show that heparin was made
available upon NIR-mediated heating, CLSM and SEM images
of Janus capsules before and after NIR irradiation were taken
(Figure S10). These images clearly displayed the disruption of
the capsules, which in turn results in the release of heparin to
enhance the photothermal-mediated thrombolysis. This is in
line with previous publications in which it was demonstrated
that laser-induced temperature increase could deconstruct the
structural integrity of gold-incorporated polymers to achieve
controlled drug release.51−54 To prove the anti-thrombus
function of Hep, another control group was designed. As wall
material, Hep was replaced with alginate to construct the EM-
JPMs, and these motors were also evaluated regarding their
performance in photothermal ablation of thrombus at the same
experimental conditions. As shown in Figure S11A and Video
S6, thrombus models still maintained their initial state with a
little ﬂuorescence quenching after laser illumination. Further-
more, two other control groups were also investigated,
including laser irradiation in the absence of EM-JPMs (Figure
S11B and Video S7) and in the presence of (CHI/Hep)5
capsules without gold coating (Figure S11C). Neither of them
could induce the ablation of the thrombus. From these
experiments, it was proven that only EM-JPMs prepared by
Hep and CHI could achieve the eﬃcient therapeutic eﬀect
toward thrombus ablation.
CONCLUSION
In summary, a photothermal thrombolytic platform based on
erythrocyte membrane-coated Janus capsule micromotors was
developed. Upon NIR irradiation, Janus capsules composed of
biomolecules and partially covered with a gold shell were able
to generate a local temperature gradient due to the strong
surface plasmon resonance adsorption. The asymmetric
structure of EM-JPMs induced rapid motion by thermophoretic
force. The movement behavior of EM-JPMs could conveniently
be modulated by the NIR laser power, as validated
experimentally. By coating the JPMs with an erythrocyte
membrane, the motors exhibited excellent performance in
movement in relevant biological environments. In addition to
providing a driving force, it was found that EM-JPMs could also
successfully ablate thrombus by photothermal therapy upon
NIR irradiation. This proof-of-concept study provides a motor-
based therapeutic system with the advantages of active
transportation, high eﬃcacy, and biological compatibility.
MATERIALS AND METHODS
Materials. Poly(ethylene imine) solution (Mw = 750 000 g/mol),
chitosan (medium molecular weight), heparin sodium salt (from
porcine intestinal mucosa), phenylmethanesulfonyl ﬂuoride, sodium
bicarbonate, ethylenediaminetetraacetic acid disodium salt dehydrate,
rhodamine B isothiocyanate, sodium chloride, ammonium ﬂuoride
(NH4F), and ﬁbrinogen from human plasma were obtained from
Sigma-Aldrich. Silica spheres with a diameter of 5 μm were obtained
from Microparticles GmbH, Germany. Protein BCA protein assay kit,
Dulbecco’s modiﬁed Eagle’s medium (DMEM, high glucose), PBS (1
×, pH 7.4), cell membrane marker (Wheat germ agglutinin, Alexa
Fluor 488 conjugate), thrombin, and Alexa Fluor 488-conjugated
ﬁbrinogen were purchased from ThermoFisher Scientiﬁc. Mini-
PROTEAN@ TGX stain-free gels, 4 × Laemmli protein sample
buﬀer, and Precision Plus Protein All Blue Standards were obtained
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from Bio-Rad. Ultrapure water (Millipore) of 18.2 MΩ·cm was used
for all experiments. All chemicals were used as received.
Preparation of Janus Polymeric Motors. CHI/Hep micro-
capsules were prepared by the LbL self-assembly method.55−57 Brieﬂy,
1 mg/mL of CHI and Hep solution containing 0.1 M NaCl was
alternatively deposited on the surface of template microparticles under
continuous shaking for 15 min. Unassembled polymer was removed by
washing three times with 0.1 M NaCl. Fluorescein-labeled CHI/Hep
microcapsules were synthesized by adding one layer of rhodamine B−
CHI during the assembly process.58−60 In order to construct Janus
capsule motors, a droplet of the CHI/Hep microparticle solution was
dropped on a hydrophilic silica slide to form a monolayer of
microparticles. After evaporation in air, a turbo sputter coater
(Quorum Technologies, K575X) was used to coat one side of the
polymeric particles with a thin gold layer (65 mV, 30 s). Ultrasound
treatment was used to redisperse the Janus polymeric particles into
aqueous solution. Next, 50 mg/mL of NH4F solution was then used to
dissolve the silica template to form Janus polymeric capsules with
hollow structure. The morphology of JPMs was characterized with
scanning electron microscopy (FEI Quanta 200, 3D FEG, Thermo-
Fisher Scientiﬁc, USA) and confocal laser scanning microscopy (Zeiss,
LSM510 META, Germany). EDX elemental mapping analysis of JPMs
was obtained by SEM (Phenom ProX, The Netherlands).
Fabrication of Erythrocyte Membrane-Camouﬂaged JPMs.
The erythrocyte membrane was isolated and prepared from peripheral
blood of healthy mice (Balb/c, male) by following the published
protocols.61 The morphology of erythrocytes and the erythrocyte
membrane was characterized by using SEM and CLSM. EM-JPMs
were obtained according to a previously reported procedure.62 Brieﬂy,
JPMs were mixed with preobtained vesicle solution of erythrocyte
membrane and then cocultured for 4 h under gentle shaking at 4 °C.
To remove excess vesicles, the resulting solution was washed by
centrifugation three times. The as-prepared EM-JPMs were then
characterized by DLS (Malvern Zetasizer Nano ZS), CLSM, BCA
protein assay, and sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE).
Biocompatibility and Biodegradability Assessment. Mouse
embryonic ﬁbroblast cells (NIH/3T3) were selected for cytotoxicity
tests. NIH/3T3 cells were cultured in DMEM medium supplemented
with 10% fetal bovine serum (FBS) and 1% penicillin−streptomycin at
37 °C in an atmosphere of 5% CO2 and 70% humidity. Exponentially
growing cells were seeded onto a 96-well plate and incubated in cell
culture medium until the cell concentration reached ∼90%. After being
washed with PBS, EM-JPMs with diﬀerent volumes (0−80 μL, ∼4.9 ×
105 per μL, counted by using a hemocytometer) were added, followed
by the standard MTT assay. The biodegradability was tested by
immersing JPMs into PBS solution (1×, pH 7.4) at 37 °C for 1, 3, 6,
and 24 h. The morphology was investigated by SEM immediately.
Motion Experiments and Analysis. For movement experiments,
NIR laser propulsion was achieved by using a two-photon laser
(Chameleon Vision, Coherent, USA) at 760 nm as the power source.
The obtained JPMs and EM-JPMs were dispersed in PBS solution, cell
culture medium, FBS, and blood. The motion frames of JPMs and
EM-JPMs were recorded by CLSM (Zeiss, LSM510 META). All the
motion experiments were performed at room temperature. The
motion coordinate information, tracking trajectories, and further
motion analysis were conducted by ImageJ. The mean square
displacement was calculated according to the published method,
MSD = (x(Δt) − x(0))2 + (y(Δt) − y(0))2.42−44 Diﬀusion coeﬃcients
(D) were calculated according to the following equation, D = MSD/(i
× Δt), where Δt is the time interval and i is the dimensional
index.42−44 Here, i is equal to 4 for two-dimensional analysis.
Generation and Photothermal Ablation of Thrombus
Models. Thrombus models were established by following the
published protocols.63 Fibrinogen from human plasma (1 mg/mL)
as the physiological source of thrombus was dissolved in a solution of
50 mM Tris-HCl (pH 7.4) and 140 mM NaCl. Thrombus formation
was induced by adding 1 U/mL thrombin and 2.5 mM CaCl2 to the
ﬁbrinogen solution, which was then cultured at 37 °C for 1 h. A
turbidity assay was used to monitor the process of thrombus formation
by measuring the absorbance (340 nm) at 10 min intervals.
Fluorescent-labeled thrombus was formed by an additional supply of
10 μL of Alexa Fluor 488-conjugated ﬁbrinogen to the ﬁbrinogen
solution containing thrombin and CaCl2, followed by incubation at 50
°C for 2 h. The ﬂuorescent thrombus was characterized by CLSM
(Leica, TCS SP5X). Thrombus models and EM-JPMs (50 μL, ∼4.9 ×
105 per μL) in a μ-slide 8 well (ibidi, Germany) were irradiated with a
760 nm laser at a laser power of 2.43 J/cm2 (two-photon laser,
Chameleon Vision, Coherent, USA). Thrombus lysis was evaluated by
a ﬂuorescence-based assay.
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Möhwald, H. Novel Hollow Polymer Shells by Colloid-Templated
Assembly of Polyelectrolytes. Angew. Chem. Int. Ed. 1998, 37, 2201−
2205.
(57) Caruso, F.; Caruso, R. A.; Möhwald, H. Nanoengineering of
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